Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_assertion type Assertion NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_head.
- NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_assertion description "[Our results demonstrate that a low MITF/AXL ratio predicts early resistance to multiple targeted drugs, and warrant clinical validation of AXL inhibitors to combat resistance of BRAF and NRAS mutant MITF-low melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_provenance.
- NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_assertion evidence source_evidence_literature NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_provenance.
- NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_assertion SIO_000772 25502142 NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_provenance.
- NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_assertion wasDerivedFrom befree-2016 NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_provenance.
- NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_assertion wasGeneratedBy ECO_0000203 NP1247691.RAVWPv7R7XJh3Lpa53bCNSR6vj-SWooui1eKXGxNBDYg8130_provenance.